ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
October 29, 2018 — At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch...
RaySearch Demonstrates New Machine Learning Applications at ASTRO
News | Radiation Therapy | October 29, 2018
October 29, 2018 — RaySearch exhibited its latest advances in oncology software at the 2018 American Society for...
Sun Nuclear Surpasses 100 Units Shipped Milestone With SRS MapCheck
News | Quality Assurance (QA) | October 26, 2018
October 26, 2018 — Sun Nuclear Corp. announced the 100th shipment of its new SRS MapCheck for stereotactic radiosurgery...
Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite
News | Radiation Therapy | October 26, 2018
October 26, 2018 — During a recent users meeting, Varian shared details of its development work on an artificial...
Brainlab Introduces ExacTrac Dynamic at ASTRO 2018
News | Patient Positioning Radiation Therapy | October 25, 2018
October 25, 2018 — Brainlab unveiled ExacTrac Dynamic at the American Society for Radiation Oncology (ASTRO) meeting,...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
October 25, 2018 — IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
October 25, 2018 — iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the...
Optune’s electrical fields disrupt the multiplication of cancer cells by delivering alternating electric fields over the region where the disease is located.

Optune’s electrical fields disrupt the multiplication of cancer cells by delivering alternating electric fields over the region where the disease is located.

Feature | Radiation Oncology | October 24, 2018 | By Greg Freiherr
They are the most difficult forms of cancer to treat — glioblastoma multiforme, pancreatic and recurrent ovarian. Their...
Siris Medical Releases PlanMD Decision Support Software
Technology | Treatment Planning | October 24, 2018
October 24, 2018 — Siris Medical Inc. announced the release of its new artificial intelligence (AI) treatment decision-...
Fujifilm Unveils FCT Embrace CT System for Oncology
Technology | Computed Tomography (CT) | October 23, 2018
October 23, 2018 — Fujifilm Medical Systems U.S.A. Inc. recently introduced the FCT Embrace computed tomography (CT)...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
October 23, 2018 — Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment, stereotactic body radiation therapy (SBRT) has long been preferred for patients...
Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects. #ASTRO #ASTRO18 #ASTRO2018
News | Radiation Therapy | October 23, 2018
October 23, 2018 — Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding...
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them better at the jobs only they can do, said speakers at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas.
Feature | Artificial Intelligence | October 22, 2018 | By Greg Freiherr
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them...
Combined Therapy Including Pelvic Lymph Node Radiation Provides Significant Benefit for Prostate Cancer Patients - late breaking study presented at ASTRO 2018.
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of prostate cancer after...
High-dose, High-precision Radiation Therapy Safe and Effective for Kidney Cancer Patients With Only One Kidney -  Renal SABR in patients with a solitary kidney: an individual-patient pooled analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK) at ASTR 2018.

Image courtesy of Vital Images

News | ASTRO | October 22, 2018
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one...
Fewer, larger individual doses of radiation lead to similar adverse effects to normal tissue after 10 years as with conventional radiation therapy for early breast cancer
News | ASTRO | October 22, 2018
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer,...
Patients whose cancer has not spread far past the lungs may benefit from targeting tumor sites with radiation or surgery after initial treatment, according to ASTRO study
News | ASTRO | October 21, 2018
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a...
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study. #ASTRO2018 #ASTRO #ASTRO18

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S. regulators do as expected,...